Zobrazeno 1 - 10
of 14
pro vyhledávání: '"F. J. Muñoz-Rodriguez"'
Autor:
Miguel Ingelmo, F. J. Muñoz-Rodriguez, Ricard Cervera, Santiago Maragall, Gerard Espinosa, Antoni Ordinas, Josep Font, Dolors Tàssies, Gines Escolar, Carolina Freire, J. Monteagudo, Joan Carles Reverter
Publikováno v:
Arthritis & Rheumatism. 43:2349-2358
Objective To investigate the relationship between the 4G/5G polymorphism of the type 1 plasminogen activator inhibitor (PAI-1) gene and thrombotic manifestations in patients with antiphospholipid syndrome (APS). Methods We studied a total of 247 pati
Publikováno v:
Clinical Rheumatology. 16:629-631
Several visual disturbances have been associated with the presence of antiphospholipid antibodies, including vaso-occlusive retinopathy and ischaemic optic neuropathy. The latter has been rarely described in patients with "primary" antiphospholipid s
Autor:
Juan Carlos Reverter, Ricard Cervera, F. J. Muñoz-Rodriguez, Josep Font, Gerard Espinosa, Francisco Carmona, Juan Balasch, Dolors Tàssies, Antonio Ordinas, Miguel Ingelmo
Publikováno v:
Lupus. 11(11)
Antiphospholipid antibodies (aPL) may induce acquired activated protein C resistance (acquired APCR). The role of acquired APCR in patients with systemic lupus erythematosus (SLE) is not well known. To evaluate the prevalenceof acquiredAPCR and its a
Publikováno v:
Clinical rheumatology. 21(4)
A variety of systemic autoimmune disorders have been reported in patients with myelodysplastic and myeloproliferative syndromes. A possible association with polymyalgia rheumatica and giant cell arteritis has also been recognised. We report another c
Autor:
Miguel Ingelmo, Dolors Tàssies, F. J. Muñoz-Rodriguez, Josep Font, Ricard Cervera, Joan Carles Reverter, Gerard Espinosa, Antoni Ordinas
Publikováno v:
Seminars in arthritis and rheumatism. 31(1)
Objectives: To evaluate the prevalence of thrombophilic risk factors known to induce intravascular clotting and to assess their relationship with ischemic manifestations in giant cell arteritis (GCA). Methods: Eighty consecutive patients with establi
Autor:
Joan Carles Reverter, Alfonso López-Soto, Gerard Espinosa, F. J. Muñoz-Rodriguez, Miguel Ingelmo, Antoni Ordinas, Richard Cervera, Joan Balasch, Josep Font, Dolors Tàssies, Francisco Carmona
Publikováno v:
Seminars in arthritis and rheumatism. 29(3)
Objectives: To study the clinical characteristics at diagnosis and during follow-upof patients with the antiphospholipid syndrome (APS) and to analyze the influence of treatment on their outcome. Patients: One hundred patients with APS were included
Autor:
Josep Font, Dolors Tàssies, F. J. Muñoz-Rodriguez, Ricard Cervera, José María Sánchez-Tapias, Antoni Ordinas, Miguel Ingelmo, Joan Carles Reverter, Roberto Mazzara
Publikováno v:
Journal of hepatology. 30(5)
Background/Aims: The aim of this study was to determine the prevalence and clinical significance of hepatitis C virus (HCV) infection in patients with the antiphospholipid syndrome (APS). Methods: A series of 88 consecutive patients (78 female and 10
Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity
Autor:
C, Miret, J, Font, R, Molina, X, Filella, J, Vivancos, F J, Muñoz-Rodriguez, R, Cervera, A M, Ballesta, M, Ingelmo
Publikováno v:
Anticancer research. 18(2B)
Recently, tumor markers (CA 125 and SCC) have been suggested as possible activity markers of systemic lupus erythematosus (SLE), but study results have been contradictory.The aim of this study was to evaluate the possible relationship between CA 125
Autor:
Joan Albert Barberà, Josep Font, Ricard Cervera, JR Badia, F. J. Muñoz-Rodriguez, Miguel Ingelmo, C Miret
Publikováno v:
Scopus-Elsevier
The pathogenesis and therapy of shrinking lungs syndrome in patients with systemic lupus erythematosus remains controversial. It has been previously reported that corticosteroid treatment can be effective. We report a patient with shrinking lungs syn
Publikováno v:
Medicina Clínica. 115:357-358